Morgan Stanley’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.5M | Sell |
4,541,526
-528,369
| -10% | -$6.6M | ﹤0.01% | 2102 |
|
|
2025
Q4 | $65.6M | Buy |
5,069,895
+4,153,741
| +453% | +$53.3M | ﹤0.01% | 1829 |
|
|
2025
Q3 | $11.8M | Buy |
916,154
+184,525
| +25% | +$2.47M | ﹤0.01% | 3390 |
|
|
2025
Q2 | $13M | Buy |
731,629
+120,633
| +20% | +$2.1M | ﹤0.01% | 3199 |
|
|
2025
Q1 | $10.9M | Buy |
610,996
+2,870
| +0.5% | +$65.2K | ﹤0.01% | 3261 |
|
|
2024
Q4 | $18.1M | Sell |
608,126
-61,995
| -9% | -$1.31M | ﹤0.01% | 2849 |
|
|
2024
Q3 | $10.5M | Sell |
670,121
-136,403
| -17% | -$2.47M | ﹤0.01% | 3396 |
|
|
2024
Q2 | $13.8M | Sell |
806,524
-950,115
| -54% | -$16.7M | ﹤0.01% | 3052 |
|
|
2024
Q1 | $27.5M | Sell |
1,756,639
-1,080,329
| -38% | -$15.9M | ﹤0.01% | 2348 |
|
|
2023
Q4 | $42.4M | Buy |
2,836,968
+1,747,348
| +160% | +$23.4M | ﹤0.01% | 2625 |
|
|
2023
Q3 | $17.6M | Buy |
1,089,620
+279,070
| +34% | +$8.05M | ﹤0.01% | 2601 |
|
|
2023
Q2 | $33.6M | Buy |
810,550
+327,956
| +68% | +$20.4M | ﹤0.01% | 1952 |
|
|
2023
Q1 | $29M | Sell |
482,594
-9,450
| -2% | -$755K | ﹤0.01% | 2041 |
|
|
2022
Q4 | $36.1M | Sell |
492,044
-442,169
| -47% | -$33.3M | ﹤0.01% | 1784 |
|
|
2022
Q3 | $71M | Sell |
934,213
-94,125
| -9% | -$7.34M | 0.01% | 1089 |
|
|
2022
Q2 | $71.5M | Buy |
1,028,338
+298,689
| +41% | +$22.5M | 0.01% | 1128 |
|
|
2022
Q1 | $60.5M | Sell |
729,649
-96,765
| -12% | -$7.13M | 0.01% | 1171 |
|
|
2021
Q4 | $62M | Sell |
826,414
-57,771
| -7% | -$5.8M | 0.01% | 1194 |
|
|
2021
Q3 | $103M | Buy |
884,185
+24,273
| +3% | +$3.67M | 0.01% | 831 |
|
|
2021
Q2 | $191M | Sell |
859,912
-375,016
| -30% | -$73M | 0.03% | 563 |
|
|
2021
Q1 | $163M | Sell |
1,234,928
-115,726
| -9% | -$18.3M | 0.02% | 554 |
|
|
2020
Q4 | $234M | Buy |
1,350,654
+28,065
| +2% | +$3.84M | 0.04% | 420 |
|
|
2020
Q3 | $147M | Sell |
1,322,589
-18,365
| -1% | -$1.47M | 0.03% | 469 |
|
|
2020
Q2 | $79.5M | Buy |
1,340,954
+107,737
| +9% | +$7.09M | 0.02% | 628 |
|
|
2020
Q1 | $83M | Sell |
1,233,217
-119,679
| -9% | -$9.46M | 0.02% | 543 |
|
|
2019
Q4 | $114M | Buy |
1,352,896
+1,108,977
| +455% | +$89.5M | 0.03% | 553 |
|
|
2019
Q3 | $18.2M | Buy |
243,919
+141,892
| +139% | +$11.3M | ﹤0.01% | 1560 |
|
|
2019
Q2 | $6.45M | Buy |
102,027
+16,150
| +19% | +$818K | ﹤0.01% | 2654 |
|
|
2019
Q1 | $4.14M | Sell |
85,877
-111,827
| -57% | -$5.38M | ﹤0.01% | 2887 |
|
|
2018
Q4 | $6.62M | Sell |
197,704
-58,704
| -23% | -$2.15M | ﹤0.01% | 2558 |
|
|
2018
Q3 | $13.4M | Sell |
256,408
-7,098
| -3% | -$283K | ﹤0.01% | 2102 |
|
|
2018
Q2 | $8.25M | Buy |
263,506
+8,944
| +4% | +$249K | ﹤0.01% | 2593 |
|
|
2018
Q1 | $5.55M | Buy |
254,562
+13,642
| +6% | +$293K | ﹤0.01% | 2915 |
|
|
2017
Q4 | $4.87M | Buy |
240,920
+14,296
| +6% | +$275K | ﹤0.01% | 3136 |
|
|
2017
Q3 | $4.5M | Buy |
226,624
+55,847
| +33% | +$1.1M | ﹤0.01% | 3066 |
|
|
2017
Q2 | $2.96M | Buy |
170,777
+62,780
| +58% | +$811K | ﹤0.01% | 3418 |
|
|
2017
Q1 | $875K | Sell |
107,997
-98,679
| -48% | -$713K | ﹤0.01% | 4479 |
|
|
2016
Q4 | $1.62M | Buy |
206,676
+155,817
| +306% | +$1.25M | ﹤0.01% | 4103 |
|
|
2016
Q3 | $434K | Buy |
50,859
+11,449
| +29% | +$104K | ﹤0.01% | 4606 |
|
|
2016
Q2 | $460K | Sell |
39,410
-224,975
| -85% | -$2.82M | ﹤0.01% | 4474 |
|
|
2016
Q1 | $3.83M | Sell |
264,385
-165,792
| -39% | -$2.38M | ﹤0.01% | 2773 |
|
|
2015
Q4 | $9.62M | Buy |
+430,177
| New | +$10.3M | ﹤0.01% | 2019 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM
